Connect with us

Technology

Medical Oxygen Concentrators Market to Reach USD 7.1 Billion by 2034, Growing at a 6.9% CAGR: Surge in Demand for Sustainable and Cost-Effective Solutions Drives Market Growth | TMR

Published

on

According to the latest medical oxygen concentrators market trends, Asia Pacific held largest share in 2023. Rise in prevalence of hospital-based pneumonia is fueling the market dynamics of the region.

WILMINGTON, Del., July 26, 2024 /PRNewswire/ — The global medical oxygen concentrators market was projected to attain US$ 3.4 billion in 2023. It is anticipated to garner a 6.9% CAGR from 2024 to 2034, and by 2034, the market is likely to attain US$ 7.1 billion.

The medical oxygen concentrator is one form of medical equipment used to provide oxygen to people with breathing-related illnesses. The respiratory mechanisms and metabolism of living things depend heavily on oxygen. An oxygen concentrator is frequently necessary for those with low blood oxygen concentrations to restore oxygen levels.

Oxygen concentrators use pressure swing adsorption to provide concentrated oxygen up to 95.5%. Using these concentrators to administer oxygen treatment is a practical and economical approach. An electronic user interface that helps with modifying the oxygen concentration levels and delivery parameters is included with medical oxygen concentrators.

Download Sample PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3998 

Medical oxygen concentrators are medical devices that are used to segregate nitrogen from air in order to extract pure oxygen. The oxygen concentrated using these devices can be up to 95% pure. The device draws air in, passes it through a filter, and then compresses it. The filters take up nitrogen and let oxygen to pass through, collecting it in a tank. Thereafter, the compressed oxygen is delivered through a facemask or open prongs beneath the nostrils via a tiny tube that extends from the device.

Portable oxygen concentrators are also available that run on rechargeable battery and are mostly equipped to supply oxygen by pulse dose, wherein tiny bursts of oxygen get released during each breathe. It is important to note that oxygen concentrators require constant power supply to operate. Medical oxygen concentrators are prescribed to patients suffering from chronic obstructive pulmonary disease (COPD), asthma, emphysema, cystic fibrosis, among others. Additionally, in high altitude locations, athletes also require oxygen concentrators in order to reduce fatigue and enhance training.

It is worth noting that in the U.S. alone, annually more than 1.5 million individuals require supplemental oxygen therapy. Further, as per estimates from the UNICEF, in low- and middle-income countries (LMICs), over 7 million children suffer from severe pneumonia every year. The rising levels of air pollution also contribute to the surging burden of respiratory diseases. The World Health Organization reports that almost the entire global population is exposed to polluted air, with LMICs suffering from highest exposures. The aforementioned factors are cumulatively leading to an increased demand for oxygen therapy. Specifically, during COVID-19 pandemic, the demand for oxygen concentrators skyrocketed as infected patients required long term oxygen therapy. The WHO estimated that 20-40% of mortality due to pneumonia, during the COVID-19 pandemic were preventable with sufficient oxygen supply. However, the recent years have witnessed numerous advancements in medical oxygen concentrator technology with the advent of precise oxygen delivery mechanisms.

Modern oxygen concentrators utilize pulse flow mechanism that dynamically accommodate to evolving requirements of the patient. In the future, oxygen concentrators are anticipated to be smaller and carried in a pocket or worn on a belt, offering respiratory care patients with enhanced mobility. Compact compressors and more efficient batteries would also allow for compact oxygen concentrators, as technology advances. With the integration of artificial intelligence and machine learning, oxygen concentrators can precisely analyze breathing patterns and modify oxygen delivery. The advent of this breakthrough technology is poised to eliminate uncertainties and result in personalized therapy regimens.

Key Findings of Market Report

Blood oxygen levels below normal constitute the medical condition known as hypoxemia.Medicinal oxygen concentrators are a useful tool for treating hypoxemia.These concentrators are a good and appropriate choice for providing oxygen at the point of care.A research published in the Lancet Global Health in 2022 found that the prevalence of hypoxemia was 31% among all children with WHO-classified pneumonia, 41% among those with very severe or severe pneumonia, and 8% among those with non-severe pneumonia.Therefore, the market demand for medical oxygen concentrators is being driven by the high frequency of hypoxemia among children who have severe pneumonia.

Market Trends for Medical Oxygen Concentrators

Refilling medical oxygen concentrators is not necessary. These concentrators provide 90% to 95% pure oxygen by continually purifying ambient air. They provide infinite oxygen and are powered by electricity. When compared to compressed gas cylinders, these concentrators are more economical.Batteries and other accessories have an impact on the cost of new home oxygen concentrators. Even less expensive are used oxygen concentrators, depending on the model, hours, and guarantee. In order to reduce the cost of concentrators, certain businesses in the medical oxygen concentrator sector are providing rental services and reconditioned oxygen concentrators.One of the primary factors preventing the medical oxygen concentrator market from growing is the lack of proper maintenance, training, equipment selection, and acquisition in developing nations.

Medical Oxygen Concentrators Market Report Scope:

Report Coverage

Details 

Forecast Period  

2024-2034

Base Year  

2020-2022

Size in 2023

US$ 3.4 Bn

Forecast (Value) in 2034

US$ 7.1 Bn

Growth Rate (CAGR) 

6.9 %

No. of Pages 

171 Pages 

Segments covered 

By Modality, By Technology, By End-user, By Region

Global Market for Medical Oxygen Concentrators: Regional Outlook

Asia Pacific accounted for the highest proportion in 2023. The region’s market dynamics are being driven by an increase in the prevalence of hospital-based pneumonia.Pneumonia in children is a serious clinical and public health concern. About 20% of all pediatric fatalities worldwide include pneumonia, with the majority of those deaths occurring in India.The market share of medical oxygen concentrators in Asia Pacific is also increasing due to the high frequency of respiratory illnesses. China accounted for 24% of all new diagnoses, 21% of all prevalent cases, 32% of all deaths, and 27% of all DALYs from chronic obstructive pulmonary disease globally in 2019, according to estimates from the Global Burden of Disease Study.

Request Table of Content Here: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=3998 

Global Medical Oxygen Concentrators Market: Competitive Landscape

In order to further improve goods and maintain their competitiveness in the market, significant companies competing in the landscape are employing direct patient input in their research and development activities.

Additionally, they provide portable electronics that are perfect for usage in homes, workplaces, and transit. The following companies are well-known participants in the global medical oxygen concentrators market:

Chart Industries Inc.Inogen Inc.Invacare CorporationKoninklijke Philips N.V.ResMed Inc.Drive DeVilbiss HealthcarePrecision Medical, Inc.Besco Medical Co., Ltd.02 Concepts, LLCGCE Group

Some key developments by the players in this market are:

In order to better service its clients in the Asia Pacific area, the oxygen supply producer CAIRE opened a brand-new, innovative medical technology center in Chengdu, China, in March 2024. Along with a variety of specific AirSep commercial oxygen concentrators, the facility will produce the Eclipse 5 portable oxygen concentrator and the VisionAire 5 stationary oxygen concentrator for the firm.O2 Concepts declared in January 2024 that the Oxlife LIBERTY, their most cutting-edge proof of concept device, now has greater continuous flow capabilities. The Oxlife LIBERTY is equipped with the business’s unique DNA Technology, an intelligent cellular technology that is launched by the device and links DMEs to device data to enable unprecedented levels of inventory control, asset management, and operating efficiency.

Global Medical Oxygen Concentrators Market Segmentation 

By Modality

PortableStationary

By Technology

Pulse FlowContinuous Flow

By End User

HospitalsHome CareAmbulatory Surgical Centers

By Region

North AmericaLatin AmericaEuropeAsia PacificMiddle East & Africa

Purchase the Report for Market-Driven Insights: https://www.transparencymarketresearch.com/checkout.php?rep_id=3998&ltype=S 

Have a Look at More Valuable Insights of Healthcare

Stethoscope Market: The global stethoscope market is likely to expand at a CAGR of 5.5% from 2022 to 2032. People today are more willing to opt for physical examinations and undertake diagnoses with the inclination toward health and fitness.Hybrid Operating Room Market: The global Hybrid Operating Room Market is expected to grow at a CAGR of 7.7% from 2022 to 2031.Oxidative Stress Assays Market is expected to grow at a CAGR of 9.4% from 2024 to 2034 and reach US$ 2.8 Bn by the end of 2034

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com   
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/medical-oxygen-concentrators-market-to-reach-usd-7-1-billion-by-2034–growing-at-a-6-9-cagr-surge-in-demand-for-sustainable-and-cost-effective-solutions-drives-market-growth–tmr-302207457.html

SOURCE Transparency Market Research

Continue Reading

Technology

LEAP Group Relaunches HumanView, a Growth Intelligence System Built to Explain Why Customers Behave the Way They Do

Published

on

By

Reimagined from the ground up, HumanView pairs statistical modeling with expert analysts to turn millions of real-world customer signals into business decisions

LOUISVILLE, Ky., Oct. 23, 2026 /PRNewswire/ — LEAP Group today announced the relaunch of HumanView, its growth intelligence service. The new version has been rebuilt from the ground up and now has a dedicated home at leapgroupnetwork.com/humanview.

HumanView analyzes what customers say and do across social platforms, e-commerce sites, review platforms, search behavior and user-generated content, including signals from Reddit, TikTok, YouTube, Meta, Amazon and Walmart+ that general AI tools cannot always access. Because the data reflects unprompted, real-world behavior, it avoids the response bias built into surveys and focus groups.

The service works in three layers. HumanView captures signals at scale, decodes millions of records through validated statistical models such as regression, correlation and clustering, and then relies on experienced analysts to interpret the patterns. Clients receive clear, human-validated insights instead of another dashboard.

“Machines find the patterns. Humans find the point,” said Alan Gilleo, CEO at LEAP Group. “The first version of HumanView showed us how much customers reveal when nobody is asking them questions. This version is built to explain why they act the way they do, and to put those answers in front of everyone making decisions, from product to service to marketing.”

HumanView focuses on three areas:

Growth Intelligence: customer motivations and how people perceive a brand and its competitors

Market and Category Intelligence: product pain points, service friction, unmet needs and competitive gaps

Audience Intelligence: new segments, positioning opportunities and gaps in the market

Every model is designed and validated by data scientists and benchmarked before it informs a recommendation.

To learn more about HumanView, visit leapgroupnetwork.com/humanview.

About LEAP Group
LEAP Group is a boutique marketing agency holding company with offices in Louisville, Indianapolis, Cincinnati and Chicago. Guided by the belief that brands should “Market Less. Matter More.,” LEAP gives clients access to specialized experts across its entire network. Learn more at leapgroupnetwork.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/leap-group-relaunches-humanview-a-growth-intelligence-system-built-to-explain-why-customers-behave-the-way-they-do-302918557.html

SOURCE LEAP Group

Continue Reading

Technology

STEPHEN A. SMITH ADDRESSES WHITE HOUSE DINNER ATTENDANCE, REAFFIRMS COMMITMENT TO HBCUs AND PROTECTING CORPORATE INVESTMENT IN BLACK EDUCATION

Published

on

By

NEW YORK, Oct. 23, 2026 /PRNewswire/ — Stephen A. Smith, media mogul, New York Times bestselling author, and proud 1991 graduate of Winston-Salem State University, is addressing the public discussion surrounding his decision to attend a White House dinner with President Donald Trump, emphasizing his commitment to the long-term financial stability of Historically Black Colleges and Universities (HBCUs).

For Smith, the decision was rooted in a commitment to institutions that have educated generations of Black leaders, professionals, entrepreneurs, and public servants.

“I will always advocate for HBCUs and the students whose futures depend on them,” Smith said. “My reason for attending the White House dinner was to discuss the challenges these institutions face in securing long-term funding and to make the case that corporate America must continue to invest in them.”

Smith acknowledged federal support through the FUTURE Act while expressing concern that political tensions surrounding diversity, equity, and inclusion (DEI) could discourage private companies from supporting HBCUs. He maintains that these institutions deserve sustained corporate partnerships, philanthropic contributions, and public investment.

“If we truly believe in free-market capitalism, businesses should be able to support educational institutions and charitable causes without fear of criticism or repercussions,” Smith said. “HBCUs have made extraordinary contributions to this country. They deserve sustained public and private investment.”

Ashley Christopher, Esq., Founder and CEO of the HBCU Week Foundation, recognized Smith’s advocacy and decision to engage with the administration.

“Stephen A. Smith has been a powerful advocate for HBCUs, using his platform and influence to shine a national spotlight on our institutions,” expressed Christopher, “His continued support of HBCU Week helps advance our mission of connecting students with life-changing educational opportunities, and we are proud to have him as our ambassador.”

Since Smith became an HBCU Week Ambassador in 2019, the initiative has facilitated more than 15,000 on-the-spot college acceptances and raised and awarded more than $150 million in scholarships, according to the HBCU Week Foundation.

As public discussion continues, Smith is emphasizing the importance of ensuring HBCUs have the resources and partnerships needed to educate future generations and expand opportunities for students.

CLICK HERE to watch Smith’s full response to his White House visit.

MEDIA CONTACT:

media@mrsasinc.com

View original content:https://www.prnewswire.com/news-releases/stephen-a-smith-addresses-white-house-dinner-attendance-reaffirms-commitment-to-hbcus-and-protecting-corporate-investment-in-black-education-302918547.html

SOURCE Straight Shooter Media

Continue Reading

Technology

Advantex Announces Completion of Financing and Extension of Maturity Date of Previously Issued Debentures

Published

on

By

TORONTO, Oct. 23, 2026 /CNW/ — Advantex Marketing International Inc. (CSE: ADX) (“Advantex”), a leader in the merchant cash advance and loyalty marketing products for merchants, today announced the completion of a $250,000 secured debt financing. Advantex issued a $250,000 non-convertible debenture which bears an interest rate at 12% per annum and matures December 15, 2027. The proceeds raised from this issuance of the Debenture will be used for working capital purposes.

Advantex has also extended the maturity of its existing $700,000 in 12% secured debentures from October 10, 2026 to December 15, 2027.

About Advantex Marketing International Inc.

Advantex provides working capital to merchants. Advantex also provides specialized marketing programs that enable members of Aeroplan to earn Aeroplan points at participating merchants.

Advantex shares trade on the Canadian Securities Exchange under the symbol ADX. For more information go to Advantex’s profile on www.sedar.com

Forward-Looking Information

This news release contains “forward-looking statements” within the meaning of applicable securities laws relating to the future business and operations of Advantex. Actual results and developments may differ materially from those contemplated by these statements. The business and operations of Advantex described herein is dependent on a number of factors and is subject to a number of risks and uncertainties. Factors that could cause actual results to differ material include, but are not limited to, changes in Advantex’s economic and competitive conditions including but not limited to the industry sectors in which Advantex operates.

The statements in this news release are made of the date of this release. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date the statements are made and Advantex undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable law.

SOURCE Advantex Marketing International Inc.

Continue Reading

Trending